• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LI Yuan,ZHOU Gang.A comparative study of risk-based drug inspection between NMPA and US FDA[J].Journal Of Pharmaceutical Research,2024,43(1):93-98[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3043times   Download 2461次 QR Code for this article
Scan with your phone!
中美药品监管机构基于风险的药品检查工作对比分析
李源,周刚
Font:Larger+|Default|Smaller-
(国家药品监督管理局药品审评中心,北京 100076)
摘要:
为持续探索完善我国基于风险启动药品注册核查的工作方法,本文对美国药品检查相关的机构和法规文件,以及批准前检查和监督检查的工作程序等进行了阐述,通过对比分析我国在实施基于风险的药品注册核查工作中存在的不足,并提出具体建议,促进我国基于风险的药品注册核查更加科学和规范化。
关键词:  基于风险  药品检查  注册核查  对比分析
DOI:10.13506/j.cnki.jpr.2024.01.017
基金项目:
Publication Date:January 25, 2024
A comparative study of risk-based drug inspection between NMPA and US FDA
LI Yuan,ZHOU Gang
(Center for Drug Evaluation,National Medical Products Administration,Beijing 100076,China)
Abstract:
In order to continue to explore and improve the working methods of risk-based drug inspection in China, this paper describes the institutions, regulatory documents and implementation procedures related to drug inspection in the United States, and analyzes the shortcomings in the implementation of risk-based drug registration inspection in China through comparison. Some specific suggestions are put forward to promote the more scientific and standardized risk-based drug registration inspection in our country.
Key words:  Risk-based  Drug inspection  Registration  Comparison and analysis
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.